UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000061156 |
|---|---|
| Receipt number | R000069986 |
| Scientific Title | Effects of blood flow restriction training on triceps surae muscle stiffness and ankle dorsiflexion range of motion |
| Date of disclosure of the study information | 2026/04/04 |
| Last modified on | 2026/04/04 10:05:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of blood flow restriction training on triceps surae muscle stiffness and ankle dorsiflexion range of motion
Acronym
Effects of blood flow restriction training on range of motion
Scientific Title
Effects of blood flow restriction training on triceps surae muscle stiffness and ankle dorsiflexion range of motion
Scientific Title:Acronym
Effects of blood flow restriction training on ankle dorsiflexion range of motion
Region
| Japan |
Condition
Condition
healthy adult men
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aimed to compare blood flow restriction at 20% and 80% of arterial occlusion pressure and to investigate the effects of different restriction intensities on ankle dorsiflexion range of motion and triceps surae muscle stiffness.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
triceps surae muscle stiffness
Key secondary outcomes
ankle dorsiflexion range of motion (non-weight-bearing/ weight-bearing), pain(Numerical Rating Scale)
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -participants are blinded
Control
Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Device,equipment | Maneuver |
Interventions/Control_1
blood flow restriction applied at 20% of arterial occlusion pressure
Interventions/Control_2
blood flow restriction applied at 80% of arterial occlusion pressure
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | < |
Age-upper limit
| 60 | years-old | >= |
Gender
Male
Key inclusion criteria
Individuals without lower limb pain or neurological symptoms
Key exclusion criteria
Individuals with obvious deformities of the lower limb joints
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Kengo |
| Middle name | |
| Last name | Kawanishi |
Organization
Morinomiya University of Medical Sciences
Division name
Inclusive Medical Sciences Research Institute
Zip code
559-8611
Address
1-26-16 Nankoukita Suminoe Ward, Osaka City, Osaka Prefecture, Japan
TEL
06-6616-6911
kengo_kawanishi@morinomiya-u.ac.jp
Public contact
Name of contact person
| 1st name | Kengo |
| Middle name | |
| Last name | Kawanishi |
Organization
Morinomiya University of Medical Sciences
Division name
Inclusive Medical Sciences Research Institute
Zip code
559-8611
Address
1-26-16 Nankokita, Suminoe-ku, Osaka-shi, Osaka, 559-8611, Japan
TEL
0666166911
Homepage URL
kengo_kawanishi@morinomiya-u.ac.jp
Sponsor or person
Institute
Morinomiya University of Medical Sciences
Institute
Department
Personal name
Kengo Kawanishi
Funding Source
Organization
Morinomiya University of Medical Sciences
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Morinomiya University of Medical Sciences
Address
1-26-16 Nankokita, Suminoe-ku, Osaka-shi, Osaka, 559-8611, Japan
Tel
0666166911
kengo_kawanishi@morinomiya-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
大阪府
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 04 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 04 | Month | 04 | Day |
Date of IRB
| 2026 | Year | 04 | Month | 03 | Day |
Anticipated trial start date
| 2026 | Year | 04 | Month | 04 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 04 | Month | 04 | Day |
Last modified on
| 2026 | Year | 04 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069986
